The questionnaire survey regarding the impact of COVID-19 pandemic on Parkinson's disease patients
We conducted the multicenter questionnaire survey targeting patients with Parkinson's disease (PD) in order to investigate the impacts on their daily lives and their requests to hospitals in the pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Mainly using open-ended questionnaire, we asked their anxiety, troubles they are facing, and requests toward hospitals in the pandemic of SARS-CoV-2. Two hundred fifth-eight PD patients answered the questionnaire. There were various opinions about anxiety such as "PD patients are susceptible and vulnerable to SARS-CoV-2" (36.8%). Concerning the troubles in the pandemic, the most frequent answer was that they couldn't participate in the rehabilitation and elderly day care (38.4%). Relatively many PD patients requested telemedicine (29.5%), whereas some people hoped face-to-face medical care (8.1%). There were demands about the delivery of medications (50.0%), the establishment of telephone consultations (43.8%), resources for rehabilitation at home (43.8%). The medical care adapted to the anxiety, trouble and requests of PD patients will be required in the era when we have to live with SARS-CoV-2.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:62 |
---|---|
Enthalten in: |
Rinsho shinkeigaku = Clinical neurology - 62(2022), 1 vom: 28. Jan., Seite 8-14 |
Sprache: |
Japanisch |
---|
Beteiligte Personen: |
Tezuka, Toshiki [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anxiety |
---|
Anmerkungen: |
Date Completed 02.02.2022 Date Revised 02.02.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.5692/clinicalneurol.cn-001663 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM334605229 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM334605229 | ||
003 | DE-627 | ||
005 | 20231225224050.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||jpn c | ||
024 | 7 | |a 10.5692/clinicalneurol.cn-001663 |2 doi | |
028 | 5 | 2 | |a pubmed24n1115.xml |
035 | |a (DE-627)NLM334605229 | ||
035 | |a (NLM)34924470 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a jpn | ||
100 | 1 | |a Tezuka, Toshiki |e verfasserin |4 aut | |
245 | 1 | 4 | |a The questionnaire survey regarding the impact of COVID-19 pandemic on Parkinson's disease patients |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 02.02.2022 | ||
500 | |a Date Revised 02.02.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a We conducted the multicenter questionnaire survey targeting patients with Parkinson's disease (PD) in order to investigate the impacts on their daily lives and their requests to hospitals in the pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Mainly using open-ended questionnaire, we asked their anxiety, troubles they are facing, and requests toward hospitals in the pandemic of SARS-CoV-2. Two hundred fifth-eight PD patients answered the questionnaire. There were various opinions about anxiety such as "PD patients are susceptible and vulnerable to SARS-CoV-2" (36.8%). Concerning the troubles in the pandemic, the most frequent answer was that they couldn't participate in the rehabilitation and elderly day care (38.4%). Relatively many PD patients requested telemedicine (29.5%), whereas some people hoped face-to-face medical care (8.1%). There were demands about the delivery of medications (50.0%), the establishment of telephone consultations (43.8%), resources for rehabilitation at home (43.8%). The medical care adapted to the anxiety, trouble and requests of PD patients will be required in the era when we have to live with SARS-CoV-2 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Parkinson’s disease | |
650 | 4 | |a anxiety | |
650 | 4 | |a multicenter questionnaire survey | |
650 | 4 | |a quality of life | |
650 | 4 | |a severe acute respiratory syndrome coronavirus 2 | |
700 | 1 | |a Osada, Takashi |e verfasserin |4 aut | |
700 | 1 | |a Terayama, Yasuo |e verfasserin |4 aut | |
700 | 1 | |a Kubota, Masahito |e verfasserin |4 aut | |
700 | 1 | |a Okusa, Shohei |e verfasserin |4 aut | |
700 | 1 | |a Shiihashi, Gen |e verfasserin |4 aut | |
700 | 1 | |a Kubo, Shin-Ichiro |e verfasserin |4 aut | |
700 | 1 | |a Suzuki, Norihiro |e verfasserin |4 aut | |
700 | 1 | |a Nakahara, Jin |e verfasserin |4 aut | |
700 | 1 | |a Seki, Morinobu |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Rinsho shinkeigaku = Clinical neurology |d 1972 |g 62(2022), 1 vom: 28. Jan., Seite 8-14 |w (DE-627)NLM000226874 |x 1882-0654 |7 nnns |
773 | 1 | 8 | |g volume:62 |g year:2022 |g number:1 |g day:28 |g month:01 |g pages:8-14 |
856 | 4 | 0 | |u http://dx.doi.org/10.5692/clinicalneurol.cn-001663 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 62 |j 2022 |e 1 |b 28 |c 01 |h 8-14 |